The Department of Justice filed an antitrust lawsuit against NewYork-Presbyterian, alleging the hospital used “all-or-nothing” contracts that blocked lower-cost plans and limited competition. The case comes just five weeks after the Justice Department filed a similar lawsuit against OhioHealth. The post DOJ Cracks Down on Unfair Contracts with New Lawsuit Against NewYork-Presbyterian appeared first on…
[Sponsored] A new eBook, sponsored by PurpleLab, examines how a significant number of patients with non-small cell lung cancer miss out on optimal care due to gaps in biomarker testing, socioeconomic barriers, incomplete patient journey data, and what can be done to change that. The post How Real-World Data Is Reshaping the NSCLC Patient Journey…
Reducing unnecessary utilization, expanding timely access to care and easing workforce burdens can help providers and health plans deliver improved healthcare for complex patient populations in the year ahead. The post Closing Behavioral Care Gaps: Three Ways Providers And Health Plans Can Reimagine Care appeared first on MedCity News.
As robotic systems grow more integrated, portable, and affordable, community hospitals will continue to play a leading role in redefining access to innovation. The post Democratizing Access: How Community Hospitals Can Drive the Next Wave of Robotic Bronchoscopy appeared first on MedCity News.
[Sponsored] Mobile clinics are expanding access to care by helping health care organizations deliver services directly to communities. The post Top Companies to Build and Operate Mobile Clinics for Your Organization appeared first on MedCity News.
Industry leaders say the No Surprises Act is protecting patients from surprise bills, but its Independent Dispute Resolution system is being overused and exploited, driving up costs and prompting calls for reform. The post ‘This is Crazy’: Health Experts Call for Changes to the No Surprises Act appeared first on MedCity News.
Denali Therapeutics’ Avlayah received FDA approval for treating Hunter syndrome, a rare neurological disorder. The biologic medicine uses Denali’s proprietary drug delivery technology to cross the protective blood-brain barrier. The post FDA Approval for Denali Therapeutics Blazes a New Trail for Brain-Penetrating Drugs appeared first on MedCity News.
Fawad Butt, CEO of Penguin Ai, gave his candid thoughts on where the healthcare AI market is headed, including how data leakage could be fueling smarter AI models and the limits of agentic AI in enterprise settings. The post Why Agentic AI is Useful But Limited & Other Hot Takes on the AI Market appeared…
As cell-based therapies grow more complex and manufacturing networks expand, resilience can’t be an afterthought, and cryopreservation can no longer just be a step that gets validated during development and left alone. It needs to play an ongoing role in product consistency, potency, and reliability. The post Frozen Does Not Mean Stable: Rethinking Cryopreservation in…
Growth without structural discipline creates risk. And the risk that has gone largely unexamined in the DPC advocacy space is the one that matters most to the broader healthcare system: what happens to insurance risk pools when healthy lives migrate out of them? The post DPC Is Scaling — The Financing Architecture Isn’t Ready appeared…